Lv1
50 积分 2025-07-01 加入
Comparable remission and health care use in real-world inflammatory bowel disease patients initiating originator biologics vs biosimilars
3个月前
已完结
Safety, Tolerability, and Pharmacodynamics of GS ‐4224 in Healthy Participants and Participants With Chronic Hepatitis B
3个月前
已完结
Response to Letter to the Editor: "Chronic Nanoplastic Exposure as a Novel Risk Amplifier for MASLD Progression"
1年前
已完结
Beyond coexistence: Unraveling the mechanistic nexus between HBV and porto-sinusoidal vascular disorder
1年前
已完结
Chronic Nanoplastic Exposure as a Novel Risk Amplifier for MASLD Progression
1年前
已完结
Nanoplastics and MASLD: Unveiling Interorgan Crosstalk and Environmental Modulators
1年前
已完结
Microplastics and human health
1年前
已完结
A Multifaceted Approach Leads to Improved Linkage to HCV Therapy: A Multicenter Randomised Controlled Trial
1年前
已完结
皖公网安备34019202002308
